DK1461017T3 - Farmaceutisk sammensætning til styret frigivelse af et beta-lactam-antibiotikum - Google Patents

Farmaceutisk sammensætning til styret frigivelse af et beta-lactam-antibiotikum

Info

Publication number
DK1461017T3
DK1461017T3 DK01274758T DK01274758T DK1461017T3 DK 1461017 T3 DK1461017 T3 DK 1461017T3 DK 01274758 T DK01274758 T DK 01274758T DK 01274758 T DK01274758 T DK 01274758T DK 1461017 T3 DK1461017 T3 DK 1461017T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
active ingredient
controlled release
composition
beta
Prior art date
Application number
DK01274758T
Other languages
English (en)
Inventor
Himadri Sen
Rajesh Suresh Kshirsagar
Shailesh Suresh Bhamare
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Application granted granted Critical
Publication of DK1461017T3 publication Critical patent/DK1461017T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
DK01274758T 2001-11-19 2001-11-19 Farmaceutisk sammensætning til styret frigivelse af et beta-lactam-antibiotikum DK1461017T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2001/000204 WO2003043607A1 (en) 2001-11-19 2001-11-19 A pharmaceutical composition for controlled release of a beta-lactam antibiotic

Publications (1)

Publication Number Publication Date
DK1461017T3 true DK1461017T3 (da) 2006-06-19

Family

ID=11076411

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01274758T DK1461017T3 (da) 2001-11-19 2001-11-19 Farmaceutisk sammensætning til styret frigivelse af et beta-lactam-antibiotikum

Country Status (11)

Country Link
US (1) US8192755B2 (da)
EP (1) EP1461017B1 (da)
AT (1) ATE319434T1 (da)
AU (1) AU2002224011B2 (da)
BR (1) BR0117171A (da)
CY (1) CY1105365T1 (da)
DE (1) DE60117712T2 (da)
DK (1) DK1461017T3 (da)
ES (1) ES2259011T3 (da)
PT (1) PT1461017E (da)
WO (1) WO2003043607A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US8124118B2 (en) 2003-10-22 2012-02-28 Lidds Ab Composition comprising biodegradable hydrating ceramics for controlled drug delivery
US7807715B2 (en) * 2006-06-09 2010-10-05 Ucb Pharma Gmbh Pharmaceutical compositions comprising fesoterodine
US9050357B2 (en) * 2010-03-08 2015-06-09 Cp Kelco U.S., Inc. Compositions and methods for producing consumables for patients with dysphagia
RU2470671C1 (ru) * 2011-07-06 2012-12-27 Государственное образовательное учреждение высшего профессионального образования "Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова Федерального агентства по здравоохранению и социальному развитию" Способ обработки текстильных изделий для сердечно-сосудистой хирургии
CN107661507A (zh) * 2017-10-30 2018-02-06 四川飞扬动物药业有限公司 兽用肠溶长效复方阿莫西林粉及其制备方法
US11554112B2 (en) * 2018-06-07 2023-01-17 Herum Therapeutics International Limited Combinations of β-lactam compounds and probenecid and uses thereof
CA3129337A1 (en) * 2019-02-13 2020-08-20 Iterum Therapeutics International Limited Combinations of beta-lactam compounds and probenecid and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6055486B2 (ja) * 1976-02-28 1985-12-05 富山化学工業株式会社 β−ラクタム環を有する化合物の直腸投与用組成物
GB8601204D0 (en) 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
US5419917A (en) 1994-02-14 1995-05-30 Andrx Pharmaceuticals, Inc. Controlled release hydrogel formulation
IL119627A (en) 1996-11-17 2002-03-10 Yissum Res Dev Co PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT
US5948440A (en) * 1997-12-17 1999-09-07 Ranbaxy Laboratories Limited Modified release matrix formulation of cefaclor and cephalexin
SK285478B6 (sk) 1998-09-14 2007-02-01 Ranbaxy Laboratories Limited Jednodenná formulácia na orálne podanie na kontrolované uvoľňovanie ciprofloxacínu
US6267986B1 (en) 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
CA2474141A1 (en) 2002-01-14 2003-07-24 The Board Of Trustees Of The University Of Illinois Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof

Also Published As

Publication number Publication date
DE60117712D1 (de) 2006-05-04
EP1461017B1 (en) 2006-03-08
US8192755B2 (en) 2012-06-05
ES2259011T3 (es) 2006-09-16
WO2003043607A1 (en) 2003-05-30
US20050031685A1 (en) 2005-02-10
EP1461017A1 (en) 2004-09-29
PT1461017E (pt) 2006-07-31
ATE319434T1 (de) 2006-03-15
AU2002224011A1 (en) 2003-06-10
AU2002224011B2 (en) 2008-05-01
CY1105365T1 (el) 2010-03-03
BR0117171A (pt) 2004-10-26
DE60117712T2 (de) 2006-11-16

Similar Documents

Publication Publication Date Title
WO2002071827A3 (en) Retinoid x receptor modulators
DE60017279D1 (en) Pyrimidinderivate
CY1105365T1 (el) Μια φαρμακευτικη συνθεση για ελεγχομενη εκλυση ενος αντιβιοτικου της β-λακταμης
ATE294159T1 (de) Herstellung von nichtkristallinem atorvastatin?calcium
WO2005069933A3 (en) Methods of treating an inflammatory-related disease
PT923934E (pt) Formulacao de matriz de libertacao modificada de cefaclor e cefalexina
NO20023313L (no) Nye substituerte benzimidazol doseringsformer og fremgangsmåte for anvendelse av samme
AU5669398A (en) Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
AU5669298A (en) Cyclosporin derivatives, their preparation and pharmaceutical compositions containing them
CA2385890A1 (en) Controlled release compositions comprising nimesulide
AP1564A (en) Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use.
HU229443B1 (en) Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use
ATE359777T1 (de) Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
WO2004058721A3 (en) Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity
WO2004019901A3 (en) Sustained release pharmaceutical composition
ATE226450T1 (de) Gepufferte orthoesterpolymere enthaltende arzneimittel
WO1998020836A3 (en) Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
HUP0500842A2 (hu) Dronedaront tartalmazó gyógyászati készítmény parenterális adagolásra
AU2001284660A1 (en) Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
WO2001017955A3 (en) Hydroxyacetamidobenzenesulphonamide derivatives
WO2002056867A3 (en) Extended release pharmaceutical compositions containing beta-lactam antibiotics
ATE361080T1 (de) Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine
AU1434201A (en) Antithrombotic agents
ATE415150T1 (de) Pharmazeutische zusammensetzung mit verzögerte freisetzung enthaltend einen cephalosporin- antibiotikum